NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
50 hedge funds and large institutions have $12.8M invested in NeuBase Therapeutics, Inc. Common Stock in 2016 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
75% less call options, than puts
Call options by funds: $307K | Put options by funds: $1.24M
Holders
50
Holding in Top 10
–
Calls
$307K
Puts
$1.24M
Top Buyers
| 1 | +$1.18M | |
| 2 | +$1.17M | |
| 3 | +$358K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$325K |
| 5 |
D.E. Shaw & Co
New York
|
+$167K |
Top Sellers
| 1 | -$2.27M | |
| 2 | -$270K | |
| 3 | -$229K | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$172K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$161K |